Percentage of patients aged 18 years and older with a diagnosis of heart failure for whom the quantitative or qualitative results of a recent or prior (any time in the past) LVEF assessment is documented within a 12 month period.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis
-
1.14 Numerator
Patients for whom the quantitative or qualitative results of a recent or prior (any time in the past) LVEF assessment is documented* within a 12 month period.
*Documentation must include documentation in a progress note of the results of an LVEF assessment, regardless of when the
evaluation of ejection fraction was performed.
Qualitative results correspond to numeric equivalents as follows:
Hyperdynamic: corresponds to LVEF greater than 70%
Normal: corresponds to LVEF 50% to 70% (midpoint 60%)
Mild dysfunction: corresponds to LVEF 40% to 49% (midpoint 45%)
Moderate dysfunction: corresponds to LVEF 30% to 39% (midpoint 35%)
Severe dysfunction: corresponds to LVEF less than 30%
-
1.15 Denominator
All patients aged 18 years and older with a diagnosis of heart failure.
-
Exclusions
None.
-
1.13a Data dictionary not attachedNo
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Cardiovascular Project 2015-2016Initial EndorsementLast UpdatedRemoval Date
-
StewardSteward Organization EmailSteward Organization Copyright
This Physician Performance Measurement Set (PPMS) and related data specifications were developed by
the Physician Consortium for Performance Improvement® (the Consortium) including the American College of Cardiology (ACC), the
American Heart Association (AHA) and the American Medical Association (AMA) to facilitate quality improvement activities by
physicians. The performance measures contained in this PPMS are not clinical guidelines and do not establish a standard of medical
care, and have not been tested for all potential applications. While copyrighted, they can be reproduced and distributed, without
modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is
defined as the sale, license, or distribution of the performance measures for commercial gain, or incorporation of the performance
measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the PPMS require a
license agreement between the user and the AMA, (on behalf of the Consortium) or the ACC or the AHA. Neither the AMA, ACC,
AHA, the Consortium nor its members shall be responsible for any use of this PPMS.
THE MEASURES AND SPECIFICATIONS ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND.
© 2011 American College of Cardiology, American Heart Association and American Medical Association. All Rights Reserved.
Limited proprietary coding is contained in the measure specifications for convenience. Users of the proprietary code sets should
obtain all necessary licenses from the owners of these code sets. The AMA, the ACC, the AHA, the Consortium and its members
disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT®) or other coding contained in the specifications.
CPT® contained in the measures specifications is copyright of the American Medical Association.
-
-
-
Risk AdjustmentRisk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-
-
-
6.1.2 Current or Planned Use(s)
-